HomeBAFNAPH • NSE
add
Bafna Pharmaceuticals Ltd
Previous close
₹73.68
Day range
₹73.00 - ₹75.40
Year range
₹69.00 - ₹113.00
Market cap
1.80B INR
Avg Volume
2.10K
P/E ratio
41.25
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 331.88M | 16.68% |
Operating expense | 81.56M | -4.00% |
Net income | 9.48M | 132.21% |
Net profit margin | 2.86 | 127.63% |
Earnings per share | — | — |
EBITDA | 26.54M | 231.91% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.15M | -83.28% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 827.51M | — |
Shares outstanding | 23.69M | — |
Price to book | 2.10 | — |
Return on assets | — | — |
Return on capital | 3.46% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 9.48M | 132.21% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1981
Website
Employees
363
